Skip to main content
Top
Published in: Supportive Care in Cancer 8/2012

01-08-2012 | Original Article

Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis

Authors: Zoe Giannousi, Ioannis Gioulbasanis, Athanasios G. Pallis, Alexandros Xyrafas, Danai Dalliani, Kostas Kalbakis, Vassilis Papadopoulos, Dimitris Mavroudis, Vassilis Georgoulias, Christos N. Papandreou

Published in: Supportive Care in Cancer | Issue 8/2012

Login to get access

Abstract

Background and aim

Cancer cachexia is a metabolic syndrome related with poor outcome. Cytokines play a key role in the pathophysiology of that syndrome. The aim of this study was to investigate the potential correlations between nutritional status, systemic inflammation, and psychological distress in cancer patients. The prognostic significance of the recorded parameters was also assessed.

Patients and methods

Patients with metastatic lung cancer were eligible. Mini Nutritional Assessment (MNA) was used for the evaluation of nutritional status, Glasgow Prognostic Score (GPS) for the estimation of systemic inflammation, and Hospital Anxiety and Depression Scale (HADS) for psychological assessment.

Results

Totally, 122 patients were enrolled (71.3% with NSCLC and 28.7% with SCLC). The following correlations were observed: MNA and GPS (r = 0.289, p = 0.001), MNA and HADS (depression scale) (r = 0.275, p = 0.002), GPS and HADS (depression scale) (r = 0.256, p = 0.004), and GPS and HADS (anxiety scale) (r = 0.194, p = 0.033). In univariate analysis, GPS (p = 0.002) and MNA (p = 0.010) emerged as significant predictors of survival. In multivariate analysis, both MNA (p = 0.032) and GPS (p = 0.020) retained their importance.

Conclusions

This study highlights the associations between nutritional status, systemic inflammation, and psychological distress, supporting their common underlying pathophysiological mechanisms and further suggesting the necessity of a holistic anti-cachectic approach.
Literature
1.
go back to reference Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497PubMedCrossRef Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497PubMedCrossRef
2.
go back to reference Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48–51PubMedCrossRef Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48–51PubMedCrossRef
3.
go back to reference Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S et al (1998) Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 20:540–548PubMedCrossRef Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S et al (1998) Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 20:540–548PubMedCrossRef
4.
go back to reference Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799PubMedCrossRef Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799PubMedCrossRef
5.
go back to reference Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495PubMedCrossRef Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495PubMedCrossRef
6.
go back to reference Houten L, Reilley AA (1980) An investigation of the cause of death from cancer. J Surg Oncol 13:111–116PubMedCrossRef Houten L, Reilley AA (1980) An investigation of the cause of death from cancer. J Surg Oncol 13:111–116PubMedCrossRef
7.
go back to reference Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Rossi FF (2006) Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 42:31–41PubMedCrossRef Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Rossi FF (2006) Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 42:31–41PubMedCrossRef
8.
go back to reference MacDonald N, Easson AM, Mazurak VC, Dunn GP, Baracos VE (2003) Understanding and managing cancer cachexia. J Am Coll Surg 197:143–161PubMedCrossRef MacDonald N, Easson AM, Mazurak VC, Dunn GP, Baracos VE (2003) Understanding and managing cancer cachexia. J Am Coll Surg 197:143–161PubMedCrossRef
9.
go back to reference Gioulbasanis I, Baracos VE, Giannousi Z, Xyrafas A, Martin L, Georgoulias V et al (2011) Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Ann Oncol 22:835–841PubMedCrossRef Gioulbasanis I, Baracos VE, Giannousi Z, Xyrafas A, Martin L, Georgoulias V et al (2011) Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Ann Oncol 22:835–841PubMedCrossRef
10.
go back to reference Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706PubMed Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706PubMed
11.
go back to reference Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–903PubMed Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–903PubMed
13.
go back to reference Illman J, Corringham R, Robinson D Jr, Davis HM, Rossi JF, Cella D et al (2005) Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 3:37–50PubMed Illman J, Corringham R, Robinson D Jr, Davis HM, Rossi JF, Cella D et al (2005) Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 3:37–50PubMed
14.
go back to reference Pallis AG, Wedding U, Lacombe D, Soubeyran P, Wildiers H (2010) Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know? Eur J Cancer 46:1019–1025PubMedCrossRef Pallis AG, Wedding U, Lacombe D, Soubeyran P, Wildiers H (2010) Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know? Eur J Cancer 46:1019–1025PubMedCrossRef
15.
go back to reference Padilla GV (1986) Psychological aspects of nutrition and cancer. Surg Clin North Am 66:1121–1135PubMed Padilla GV (1986) Psychological aspects of nutrition and cancer. Surg Clin North Am 66:1121–1135PubMed
16.
go back to reference Lesko LM (1989) Psychosocial issues in the diagnosis and management of cancer cachexia and anorexia. Nutrition 5:114–116PubMed Lesko LM (1989) Psychosocial issues in the diagnosis and management of cancer cachexia and anorexia. Nutrition 5:114–116PubMed
17.
19.
go back to reference Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887–899PubMedCrossRef Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887–899PubMedCrossRef
20.
go back to reference Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S et al (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158:1252–1257PubMedCrossRef Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S et al (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158:1252–1257PubMedCrossRef
21.
go back to reference Kraus MR, Schafer A, Al-Taie O, Scheurlen M (2005) Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepat 12:96–100PubMedCrossRef Kraus MR, Schafer A, Al-Taie O, Scheurlen M (2005) Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepat 12:96–100PubMedCrossRef
22.
go back to reference Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714PubMedCrossRef Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714PubMedCrossRef
24.
go back to reference Huhmann MB, Cunningham RS (2005) Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol 6:334–343PubMedCrossRef Huhmann MB, Cunningham RS (2005) Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol 6:334–343PubMedCrossRef
25.
go back to reference McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226PubMedCrossRef McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226PubMedCrossRef
26.
go back to reference McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262PubMedCrossRef McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262PubMedCrossRef
27.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef
28.
go back to reference Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488PubMedCrossRef Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488PubMedCrossRef
29.
go back to reference Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L (2004) The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer 12:821–825PubMedCrossRef Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L (2004) The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer 12:821–825PubMedCrossRef
30.
go back to reference Collet D (1994) Modelling survival data in medical research, 3rd edn. Blackwell Scientific, Oxford Collet D (1994) Modelling survival data in medical research, 3rd edn. Blackwell Scientific, Oxford
31.
go back to reference Walsh D, Doona M, Molnar M, Lipnickey V (2000) Symptom control in advanced cancer: important drugs and routes of administration. Semin Oncol 27:69–83PubMed Walsh D, Doona M, Molnar M, Lipnickey V (2000) Symptom control in advanced cancer: important drugs and routes of administration. Semin Oncol 27:69–83PubMed
32.
go back to reference Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 11:971–975PubMedCrossRef Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 11:971–975PubMedCrossRef
33.
go back to reference Chang VT, Hwang SS, Feuerman M, Kasimis BS (2000) Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88:1175–1183PubMedCrossRef Chang VT, Hwang SS, Feuerman M, Kasimis BS (2000) Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88:1175–1183PubMedCrossRef
34.
go back to reference Nitenberg G, Raynard B (2000) Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34:137–168PubMedCrossRef Nitenberg G, Raynard B (2000) Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34:137–168PubMedCrossRef
35.
go back to reference Tewari N, Martin-Ucar AE, Black E, Beggs L, Beggs FD, Duffy JP et al (2007) Nutritional status affects long term survival after lobectomy for lung cancer. Lung Cancer 57:389–394PubMedCrossRef Tewari N, Martin-Ucar AE, Black E, Beggs L, Beggs FD, Duffy JP et al (2007) Nutritional status affects long term survival after lobectomy for lung cancer. Lung Cancer 57:389–394PubMedCrossRef
36.
go back to reference Bauer JD, Capra S (2005) Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy–a pilot study. Support Care Cancer 13:270–274PubMedCrossRef Bauer JD, Capra S (2005) Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy–a pilot study. Support Care Cancer 13:270–274PubMedCrossRef
37.
go back to reference Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK et al (2011) An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 104:726–734PubMedCrossRef Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK et al (2011) An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 104:726–734PubMedCrossRef
38.
go back to reference Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, Kaasa S et al (2010) Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 18:273–279PubMedCrossRef Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, Kaasa S et al (2010) Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 18:273–279PubMedCrossRef
39.
go back to reference Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009:693458PubMedCrossRef Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009:693458PubMedCrossRef
40.
go back to reference Chasen MR, Dippenaar AP (2008) Cancer nutrition and rehabilitation-its time has come! Curr Oncol 15:117–122PubMed Chasen MR, Dippenaar AP (2008) Cancer nutrition and rehabilitation-its time has come! Curr Oncol 15:117–122PubMed
41.
go back to reference Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P (2010) Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcome 8:104CrossRef Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P (2010) Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcome 8:104CrossRef
Metadata
Title
Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis
Authors
Zoe Giannousi
Ioannis Gioulbasanis
Athanasios G. Pallis
Alexandros Xyrafas
Danai Dalliani
Kostas Kalbakis
Vassilis Papadopoulos
Dimitris Mavroudis
Vassilis Georgoulias
Christos N. Papandreou
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1282-x

Other articles of this Issue 8/2012

Supportive Care in Cancer 8/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine